Chemotherapy induced refractory anaemia with ring sideroblasts in carcinoma breast.
Dhot
P S
PS
Department of Haematology and Medical Oncology, A.I.I.M.S. Ansari Nagar, New Delhi.
Sharma
M C
MC
Kumar
L
L
Saxena
R
R
D000368:Aged; D000753:Anemia, Refractory / Q000097:blood / Q000139:chemically induced*; D000756:Anemia, Sideroblastic / Q000097:blood / Q000139:chemically induced*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology; D001943:Breast Neoplasms / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy; D002277:Carcinoma / Q000097:blood / Q000188:drug therapy* / Q000532:radiotherapy; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000009:adverse effects / Q000627:therapeutic use; D004317:Doxorubicin / Q000009:adverse effects / Q000627:therapeutic use; D005260:Female; D005472:Fluorouracil / Q000009:adverse effects / Q000627:therapeutic use; D006801:Humans; D008727:Methotrexate / Q000009:adverse effects / Q000627:therapeutic use; D010440:Peptichemio / Q000009:adverse effects / Q000627:therapeutic use; D018714:Radiotherapy, Adjuvant
D004317:Doxorubicin; D003520:Cyclophosphamide; D010440:Peptichemio; D005472:Fluorouracil; D008727:Methotrexate